[{"address1": "2150 St. ElzEar Boulevard West", "city": "Laval", "state": "QC", "zip": "H7L 4A8", "country": "Canada", "phone": "514 744 6792", "website": "https://www.bauschhealth.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.", "fullTimeEmployees": 20270, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas J. Appio", "age": 61, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 2744766, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John S. Barresi", "age": 50, "title": "Senior VP, Controller, Chief Accounting Officer & Interim CFO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 796804, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Seana  Carson", "age": 50, "title": "Executive VP & General Counsel", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 872648, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mirza  Dautbegovic", "title": "Executive VP & COO", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen  Fitzpatrick", "title": "Executive VP and Chief HR & Communications Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Josh  Coyle", "title": "Senior Vice President of Sales & Salix", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tage  Ramakrishna M.D.", "age": 49, "title": "Chief Medical Officer and President of R&D", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Hartness", "title": "Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Graham  Jackson", "title": "Senior VP & Chief Quality Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cees  Heiman", "title": "Senior Vice President of Europe & Canada", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 2, "compensationRisk": 5, "shareHolderRightsRisk": 3, "overallRisk": 3, "governanceEpochDate": 1719792000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.88, "open": 5.92, "dayLow": 5.685, "dayHigh": 6.04, "regularMarketPreviousClose": 5.88, "regularMarketOpen": 5.92, "regularMarketDayLow": 5.685, "regularMarketDayHigh": 6.04, "exDividendDate": 1289347200, "fiveYearAvgDividendYield": 6.52, "beta": 0.77, "forwardPE": 1.4399039, "volume": 5031631, "regularMarketVolume": 5031631, "averageVolume": 3932336, "averageVolume10days": 9737450, "averageDailyVolume10Day": 9737450, "bidSize": 2900, "askSize": 1800, "marketCap": 2202792448, "fiftyTwoWeekLow": 3.96, "fiftyTwoWeekHigh": 11.46, "priceToSalesTrailing12Months": 0.24568287, "fiftyDayAverage": 6.7422, "twoHundredDayAverage": 7.7823, "currency": "USD", "enterpriseValue": 24479113216, "profitMargins": -0.05075, "floatShares": 306179895, "sharesOutstanding": 366796992, "sharesShort": 18270547, "sharesShortPriorMonth": 18024841, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0498, "heldPercentInsiders": 0.01069, "heldPercentInstitutions": 0.80047, "shortRatio": 6.42, "shortPercentOfFloat": 0.0539, "impliedSharesOutstanding": 367744992, "bookValue": -3.041, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -455000000, "trailingEps": -1.24, "forwardEps": 4.16, "pegRatio": 0.63, "lastSplitFactor": "2:1", "lastSplitDate": 971654400, "enterpriseToRevenue": 2.73, "enterpriseToEbitda": 8.276, "52WeekChange": -0.38311023, "SandP52WeekChange": 0.18961596, "lastDividendDate": 1402444800, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "BHC", "underlyingSymbol": "BHC", "shortName": "Bausch Health Companies Inc.", "longName": "Bausch Health Companies Inc.", "firstTradeDateEpochUtc": 764951400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9e7b84f3-aa99-3efa-83c3-c9d91980d6fa", "messageBoardId": "finmb_345779", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.99, "targetHighPrice": 13.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.14, "targetMedianPrice": 8.0, "recommendationMean": 2.9, "recommendationKey": "hold", "numberOfAnalystOpinions": 7, "totalCash": 733000000, "totalCashPerShare": 1.998, "ebitda": 2958000128, "totalDebt": 22073999360, "quickRatio": 0.631, "currentRatio": 1.225, "totalRevenue": 8965999616, "revenuePerShare": 24.512, "returnOnAssets": 0.04042, "freeCashflow": 797124992, "operatingCashflow": 1088999936, "revenueGrowth": 0.108, "grossMargins": 0.70812, "ebitdaMargins": 0.32991, "operatingMargins": 0.13888, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-29"}]